© 1995 American Heart Association, Inc.
Articles |
Regulation of Vascular Endothelial Growth Factor in Cardiac Myocytes
From the Cardiology Division (A.P.L., N.S.L., A.C., N.T., G.K., W.C.) and the Hematology-Oncology Division (M.A.G.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; the Department of Pathology, Beth Israel Hospital and Harvard Medical School (K.-T.Y.); and the Whitaker Cardiovascular Institute and Cardiology Division, Evans Department of Medicine, Boston University School of Medicine (J.L.), Boston, Mass.
Abstract Collateral blood vessels supplement normal coronary blood flow and coronary blood flow compromised by coronary artery disease, thereby protecting the myocardium from ischemia. Collateral vessel formation is the result of angiogenesis. Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), is a secreted mitogen specific for endothelial cells and an extremely potent angiogenic factor. In the present study, VPF/VEGF mRNA and protein were demonstrated to be markedly stimulated in primary rat cardiac myocytes in vitro in response to reduction of the oxygen tension to 1% or inhibition of the electron transport chain. Four isoforms of VPF/VEGF were coordinately regulated by hypoxia, including a novel isoform not previously described. Phorbol ester and the depolarizing agent veratridine, stimulators of protein kinase C and calcium influx, respectively, were found to markedly increase VPF/VEGF mRNA expression in cardiac myocytes. Forskolin, a potent stimulator of adenylate cyclase, produced a small but significant increase in VPF/VEGF mRNA expression in the cardiac myocytes. However, only H7, an inhibitor of protein kinase C, inhibited the hypoxic induction of VPF/VEGF mRNA; inhibitors of calcium influx and the calcium-calmodulin–dependent protein kinase II as well as inhibition of protein kinase A did not block the hypoxic induction of VPF/VEGF mRNA. This suggests that more than one signal transduction pathway is involved in regulating VPF/VEGF expression. The sensor that regulates the expression of hypoxia-responsive genes has been proposed to be a heme protein. Consistent with this model, transition metals initiate a genetic program similar to hypoxia. In the present study, the transition metals cobalt and manganese increased VPF/VEGF mRNA in cardiac myocytes in vitro and myocardial tissue in vivo, providing evidence that a similar sensor may regulate VPF/VEGF in the cardiac myocyte. These data suggest a novel mechanism by which VPF/VEGF induction contributes to collateral vessel formation in ischemic myocardium and also suggest strategies to increase VPF/VEGF production in vivo.
Key Words: neovascularization • coronary disease • cell hypoxia • cobalt • manganese
This article has been cited by other articles:
 |
|
 |
|
  Y. Izumiya, I. Shiojima, K. Sato, D. B. Sawyer, W. S. Colucci, and K. Walsh Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload Hypertension, May 1, 2006; 47(5): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kobayashi, Y. Nishimura, T. Shimada, S. Yoshimura, Y. Funada, M. Satouchi, and M. Yokoyama Effect of Continuous Positive Airway Pressure on Soluble CD40 Ligand in Patients With Obstructive Sleep Apnea Syndrome Chest, March 1, 2006; 129(3): 632 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Terai, Y. Hiramoto, M. Masaki, S. Sugiyama, T. Kuroda, M. Hori, I. Kawase, and H. Hirota AMP-Activated Protein Kinase Protects Cardiomyocytes against Hypoxic Injury through Attenuation of Endoplasmic Reticulum Stress Mol. Cell. Biol., November 1, 2005; 25(21): 9554 - 9575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-s. Yoon, S. Uchida, O. Masuo, M. Cejna, J.-S. Park, H.-c. Gwon, R. Kirchmair, F. Bahlman, D. Walter, C. Curry, et al. Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy: Restoration of Microvascular Homeostasis and Recovery of Cardiac Function in Diabetic Cardiomyopathy After Replenishment of Local Vascular Endothelial Growth Factor Circulation, April 26, 2005; 111(16): 2073 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Marfella, K. Esposito, F. Nappo, M. Siniscalchi, F. C. Sasso, M. Portoghese, M. Pia Di Marino, A. Baldi, S. Cuzzocrea, C. Di Filippo, et al. Expression of Angiogenic Factors During Acute Coronary Syndromes in Human Type 2 Diabetes Diabetes, September 1, 2004; 53(9): 2383 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Shie, G. Wu, J. Wu, F.-F. Liu, R. J. Laham, P. Oettgen, and J. Li RTEF-1, a Novel Transcriptional Stimulator of Vascular Endothelial Growth Factor in Hypoxic Endothelial Cells J. Biol. Chem., June 11, 2004; 279(24): 25010 - 25016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Hussain, H. Kotz, L. Minasian, A. Premkumar, G. Sarosy, E. Reed, S. Zhai, S. M. Steinberg, M. Raggio, V. K. Oliver, et al. Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer J. Clin. Oncol., December 1, 2003; 21(23): 4356 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W Weiss, W. S Speidl, C. Kaun, G. Rega, C. Springer, K. Macfelda, U. M Losert, S. L Grant, M. L Marro, A. D Rhodes, et al. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes Cardiovasc Res, September 1, 2003; 59(3): 628 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gardner and M. E. Olah Distinct Protein Kinase C Isoforms Mediate Regulation of Vascular Endothelial Growth Factor Expression by A2A Adenosine Receptor Activation and Phorbol Esters in Pheochromocytoma PC12 Cells J. Biol. Chem., April 18, 2003; 278(17): 15421 - 15428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. P. Kodavanti, C. F. Moyer, A. D. Ledbetter, M. C. Schladweiler, D. L. Costa, R. Hauser, D. C. Christiani, and A. Nyska Inhaled Environmental Combustion Particles Cause Myocardial Injury in the Wistar Kyoto Rat Toxicol. Sci., February 1, 2003; 71(2): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Parenti, L. Brogelli, S. Filippi, S. Donnini, and F. Ledda Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1 Cardiovasc Res, July 1, 2002; 55(1): 201 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lavie, H. Kraiczi, A. Hefetz, H. Ghandour, A. Perelman, J. Hedner, and P. Lavie Plasma Vascular Endothelial Growth Factor in Sleep Apnea Syndrome: Effects of Nasal Continuous Positive Air Pressure Treatment Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1624 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shimizu, M. Yamato, Y. Isoi, T. Akutsu, T. Setomaru, K. Abe, A. Kikuchi, M. Umezu, and T. Okano Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces Circ. Res., February 22, 2002; 90 (3): e40 - e48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Clyman, S. R. Seidner, H. Kajino, C. Roman, C. J. Koch, N. Ferrara, N. Waleh, F. Mauray, Y. Q. Chen, E. A. Perkett, et al. VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R199 - R206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Quintana, L. Kopcow, G. Marconi, C. Sueldo, G. Speranza, and R.I. Baranao Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis Hum. Reprod., September 1, 2001; 16(9): 1814 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Endoh, T. Kaneko, H. Nakamura, K. Doi, and E. Takahashi Improved cardiac contractile functions in hypoxia-reoxygenation in rats treated with low concentration Co2+ Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2713 - H2719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.B.J Burton, V.J Owen, S Hafizi, P.J.R Barton, G Carr-White, T Koh, A De Souza, M.H Yacoub, and J.R Pepper Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery Eur. Heart J., October 2, 2000; 21(20): 1708 - 1713. [Abstract] [PDF]
|
|
|
|
 |
|
 M. E. Olah and F. L. Roudabush Down-Regulation of Vascular Endothelial Growth Factor Expression after A2A Adenosine Receptor Activation in PC12 Pheochromocytoma Cells J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 779 - 787. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. H. Lee, P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson, and P. A. Thistlethwaite Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction N. Engl. J. Med., March 2, 2000; 342(9): 626 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Clauss and W. Schaper Vascular Endothelial Growth Factor : A Jack-of-All-Trades or a Nonspecific Stress Gene? Circ. Res., February 18, 2000; 86(3): 251 - 252. [Full Text] [PDF]
|
|
|
|
 |
|
 M.A. Breider, A.W. Gough, J.R. Haskins, G. Sobocinski, and F.A. De La Iglesia Troglitazone-Induced Heart and Adipose Tissue Cell Proliferation in Mice Toxicol Pathol, September 1, 1999; 27(5): 545 - 552. [Abstract] [PDF]
|
|
|
|
|
|
A. Schultz, L. Lavie, I. Hochberg, R. Beyar, T. Stone, K. Skorecki, P. Lavie, A. Roguin, and A. P. Levy Interindividual Heterogeneity in the Hypoxic Regulation of VEGF : Significance for the Development of the Coronary Artery Collateral Circulation Circulation, August 3, 1999; 100(5): 547 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Gu, A. L. Brady, V. Anand, M. C. Moore, W. C. Kelly, and T. H. Adair Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H595 - H602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia Cardiovasc Res, July 1, 1999; 43(1): 44 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takahashi, Y. Seko, E. Noiri, K. Tobe, T. Kadowaki, H. Sabe, and Y. Yazaki Vascular Endothelial Growth Factor Induces Activation and Subcellular Translocation of Focal Adhesion Kinase (p125FAK) in Cultured Rat Cardiac Myocytes Circ. Res., May 28, 1999; 84(10): 1194 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsui, Y. Ihara, Y. Fujio, K. Kunisada, S. Akira, T. Kishimoto, and K. Yamauchi-Takihara Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-{kappa}B and NF-IL6 in cardiac myocytes Cardiovasc Res, April 1, 1999; 42(1): 104 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Tomanek, N. Hu, B. Phan, and E. B Clark Rate of coronary vascularization during embryonic chicken development is influenced by the rate of myocardial growth Cardiovasc Res, March 1, 1999; 41(3): 663 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Acarregui, S. T. Penisten, K. L. Goss, K. Ramirez, and J. M. Snyder Vascular Endothelial Growth Factor Gene Expression in Human Fetal Lung In Vitro Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 14 - 23. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. H. Marti and W. Risau Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors PNAS, December 22, 1998; 95(26): 15809 - 15814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Koudssi, J. E. Lopez, S. Villegas, and C. S. Long Cardiac Fibroblasts Arrest at the G1/S Restriction Point in Response to Interleukin (IL)-1beta . EVIDENCE FOR IL-1beta -INDUCED HYPOPHOSPHORYLATION OF THE RETINOBLASTOMA PROTEIN J. Biol. Chem., October 2, 1998; 273(40): 25796 - 25803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, A. Hach, and C. Wang Molecular Mechanism Governing Heme Signaling in Yeast: a Higher-Order Complex Mediates Heme Regulation of the Transcriptional Activator HAP1 Mol. Cell. Biol., July 1, 1998; 18(7): 3819 - 3828. [Abstract] [Full Text]
|
|
|
|
|
|
N. S. Levy, S. Chung, H. Furneaux, and A. P. Levy Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR J. Biol. Chem., March 13, 1998; 273(11): 6417 - 6423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Graven, R. J. McDonald, and H. W. Farber Hypoxic regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase Am J Physiol Cell Physiol, February 1, 1998; 274(2): C347 - C355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kim, R. Y. Imdad, A. H. Stephenson, R. S. Sprague, and A. J. Lonigro Vascular Endothelial Growth Factor mRNA in Pericytes Is Upregulated by Phorbol Myristate Acetate Hypertension, January 1, 1998; 31(1): 511 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Luo, M. Diaco, T. Murohara, N. Ferrara, J. M. Isner, and J. F. Symes Vascular Endothelial Growth Factor Attenuates Myocardial Ischemia-Reperfusion Injury Ann. Thorac. Surg., October 1, 1997; 64(4): 993 - 998. [Abstract] [Full Text]
|
|
|
|
|
|
D. S. Winlaw Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases Ann. Thorac. Surg., October 1, 1997; 64(4): 1204 - 1211. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Hayashi, K. Abe, H. Suzuki, and Y. Itoyama Rapid Induction of Vascular Endothelial Growth Factor Gene Expression After Transient Middle Cerebral Artery Occlusion in Rats Stroke, October 1, 1997; 28(10): 2039 - 2044. [Abstract] [Full Text]
|
|
|
|
|
|
B. S Lewis, M. Y Flugelman, A. Weisz, I. Keren-Tal, and W. Schaper Angiogenesis by gene therapy: a new horizon for myocardial revascularization? Cardiovasc Res, September 1, 1997; 35(3): 490 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Maxwell, G. U. Dachs, J. M. Gleadle, L. G. Nicholls, A. L. Harris, I. J. Stratford, O. Hankinson, C. W. Pugh, and P. J. Ratcliffe Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth PNAS, July 22, 1997; 94(15): 8104 - 8109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Y. Cheung Vascular Endothelial Growth Factor: Possible Role in Fetal Development and Placental Function Reproductive Sciences, July 1, 1997; 4(4): 169 - 177. [Abstract] [PDF]
|
|
|
|
|
|
T. Horiuchi and P. F. Weller Expression of Vascular Endothelial Growth Factor by Human Eosinophils: Upregulation by Granulocyte Macrophage Colony-stimulating Factor and Interleukin-5 Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 70 - 77. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. S. Pepper Manipulating Angiogenesis: From Basic Science to the Bedside Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 605 - 619. [Abstract] [Full Text]
|
|
|
|
|
|
J.-W. Gu, D. Santiago, Y. Olowe, and J. Weinberger Basic Fibroblast Growth Factor as a Biochemical Marker of Exercise-Induced Ischemia Circulation, March 4, 1997; 95(5): 1165 - 1168. [Abstract] [Full Text]
|
|
|
|
|
|
W. Schaper and W. D. Ito Molecular Mechanisms of Coronary Collateral Vessel Growth Circ. Res., November 1, 1996; 79(5): 911 - 919. [Full Text]
|
|
|
|
|
|
A. P. Levy, N. S. Levy, and M. A. Goldberg Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau Protein J. Biol. Chem., October 11, 1996; 271(41): 25492 - 25497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Kovacs, K. Ikezaki, K. Samoto, T. Inamura, M. Fukui, T. Kawamata, and S. P. Finklestein VEGF and flt: Expression Time Kinetics in Rat Brain Infarct Stroke, October 1, 1996; 27(10): 1865 - 1873. [Abstract] [Full Text]
|
|
|
|
|
|
M. Fujita, M. Ikemoto, M. Kishishita, H. Otani, R. Nohara, T. Tanaka, S.-i. Tamaki, A. Yamazato, and S. Sasayama Elevated Basic Fibroblast Growth Factor in Pericardial Fluid of Patients With Unstable Angina Circulation, August 15, 1996; 94(4): 610 - 613. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Levy, N. S. Levy, and M. A. Goldberg Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia J. Biol. Chem., February 2, 1996; 271(5): 2746 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pal, K. Datta, R. Khosravi-Far, and D. Mukhopadhyay Role of Protein Kinase Czeta in Ras-mediated Transcriptional Activation of Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression J. Biol. Chem., January 19, 2001; 276(4): 2395 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kimura, Y. Mizukami, T. Miura, K. Fujimoto, S. Kobayashi, and M. Matsuzaki Orphan G Protein-coupled Receptor, GPR41, Induces Apoptosis via a p53/Bax Pathway during Ischemic Hypoxia and Reoxygenation J. Biol. Chem., July 6, 2001; 276(28): 26453 - 26460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimizu, M. Yamato, Y. Isoi, T. Akutsu, T. Setomaru, K. Abe, A. Kikuchi, M. Umezu, and T. Okano Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces Circ. Res., February 22, 2002; 90 (3): e40 - e48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. JIANG, H. LU, K. A. VINCENT, S. SHANKARA, A. J. BELANGER, S. H. CHENG, G. Y. AKITA, R. A. KELLY, M. A. GOLDBERG, and R. J. GREGORY Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1{alpha} Physiol Genomics, February 11, 2002; 8(1): 23 - 32. [Abstract] [Full Text] [PDF]
|
|